The cerebral and cardiovascular effects of cisatracurium and atracurium in neurosurgical patients

Anesthesia and Analgesia

Volumn 86, Issue 1, 1998, Pages 123-127

  Schramm, Wolfgang M ^a   Papousek, Angelika ^a   Michalek Sauberer, Andrea ^a   Czech, Thomas ^b   Illievich, Udo ^a  

^a UNIVERSITY OF VIENNA   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ATRACURIUM; ATRACURIUM BESILATE; CISATRACURIUM; HISTAMINE;

ADULT; ARTICLE; BRAIN BLOOD FLOW; BRAIN PERFUSION; CARDIOVASCULAR EFFECT; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; FLUSHING; HEART RATE; HISTAMINE RELEASE; HUMAN; INTRACRANIAL PRESSURE; INTRAVENOUS DRUG ADMINISTRATION; MEAN ARTERIAL PRESSURE; NEUROMUSCULAR BLOCKING; NEUROSURGERY; PRIORITY JOURNAL;

ADULT; AGED; ATRACURIUM; CEREBROVASCULAR CIRCULATION; HEMODYNAMIC PROCESSES; HUMANS; INTRACRANIAL PRESSURE; MIDDLE AGED; NEUROMUSCULAR BLOCKING AGENTS; NEUROMUSCULAR NONDEPOLARIZING AGENTS; NEUROSURGERY;

EID: 0031975330     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000539-199801000-00025     Document Type: Article

References (32)

1. Werba A, Klezl M, Schramm W, et al. The level of neuromuscular block needed to suppress diaphragmatic movement during tracheal suction in patients with raised intracranial pressure: a study with vecuronium and atracurium. Anaesthesia 1993;48: 301-3.
2. Werba A, Weinstabl C, Petricek W, et al. Requisite muscle relaxation using vecuronium for tracheobronchial suction in neurosurgical intensive care patients. Anaesthesist 1991;40: 328-31.
3. Lien CA, Belmont MR, Abalos A, et al. The cardiovascular effects and histamine-releasing properties of 51W89 in patients receiving nitrous oxide/opioid/barbiturate anesthesia. Anesthesiology 1995;82:1131-8.
4. Wastila WB, Maehr RB, Turner GL, et al. Comparative pharmacology of cisatracurium (51W89), atracurium, and five isomers in cats. Anesthesiology 1996;85:169-77.
5. Eastwood NB, Boyd AH, Parker CJ, Hunter JM. Pharmacokinetics of 1R-cis 1′R-cis atracurium besylate (51W89) and plasma laudanosine concentrations in health and chronic renal failure. Br J Anaesth 1995;75:431-5.
6. Belmont MR, Lien CA, Quessy S, et al. The clinical neuromuscular pharmacology of 51W89 in patients receiving nitrous oxide/opioid/barbiturate anesthesia. Anesthesiology 1995;82: 1139-45.
7. Sokoll MD, Gergis SD, Mehta M, et al. Safety and efficacy of atracurium (BW33A) in surgical patients receiving balanced or isoflurane anesthesia. Anesthesiology 1983;58:450-5.
8. Bishop CC, Powell S, Rutt D, Browse NL. Transcranial Doppler measurement of middle cerebral artery blood flow velocity: a validation study. Stroke 1986;17:913-5.
9. Hsiang JK, Chesnut RM, Crisp CB, et al. Early, routine paralysis for intracranial pressure control in severe head injury: is it necessary? Crit Care Med 1994;22:1471-6.
10. Konstadt SN, Reich DL, Stanley TE, et al. A two-center comparison of the cardiovascular effects of cisatracurium (Nimbex) and vecuronium in patients with coronary artery disease. Anesth Analg 1995;81:1010-4.
11. Giffin JP, Litwak B, Cottrell JE, et al. Intracranial pressure mean arterial pressure and heart rate after rapid paralysis with atracurium in cats. Can Anaesth Soc J 1985;32:618-21.
12. Ducey JP, Deppe SA, Foley KT. A comparison of the effects of suxamethonium, atracurium and vecuronium on intracranial hemodynamics in swine. Anaesth Intensive Care 1989;17: 448-55.
13. Rosa G, Orfei P, Sanfilippo M, et al. The effects of atracurium besylate (Tracrium) on intracranial pressure and cerebral perfusion pressure. Anesth Analg 1986;65:381-4.
14. Minton MD, Stirt JA, Bedford RF, Haworth C. Intracranial pressure after atracurium in neurosurgical patients. Anesth Analg 1985;64:1113-6.
15. Lanier WL, Milde JH, Michenfelder JD. The cerebral effects of pancuronium and atracurium in halothane-anesthetized dogs. Anesthesiology 1985;63:589-97.
16. D'Eramo C, Avolio C, Pagliari S. Atracurium in patients with head injuries. Miner Anestesiol 1990;56:893-5.
17. Haigh JD, Nemoto EM, DeWolf AM, Bleyaert AL. Comparison of the effects of succinylcholine and atracurium on intracranial pressure in monkeys with intracranial hypertension. Can Anaesth Soc J 1986;33:421-6.
18. Unni VK, Gray WJ, Young HS. Effects of atracurium on intracranial pressure in man. Anaesthesia 1986;41:1047-9.
19. McClelland M, Woster P, Sweasey T, Hoff JT. Continuous midazolam/atracurium infusions for the management of increased intracranial pressure. J Neurosci Nurs 1995;27:96-101.
20. Tarkkanen L, Laitinen L, Johanssohn G. Effects of d-tubocurarine on intracranial pressure and thalamic electrical impedance. Anesthesiology 1974;40:247-52.
21. Monnier M, Hatt A. Afferent and central activating effects of histamine on the brain. Experientia 1969;25:1297-8.
22. Adt M, Baumert JH, Reimann HJ. The role of histamine in the cardiovascular effects of atracurium. Br J Anaesth 1992;68: 155-60.
23. Naguib M, Samarkandi AH, Bakhamees HS, et al. Histamine-release hemodynamic changes produced by rocuronium, vecuronium, mivacurium, atracurium and tubocurarine. Br J Anaesth 1995;75:588-92.
24. Hosking MP, Lennon RL, Gronert GA. Combined H1 and H2 receptor blockade attenuates the cardiovascular effects of high-dose atracurium for rapid sequence endotracheal intubation. Anesth Analg 1988;67:1089-92.
25. Sethna DH, Starr NJ, Estafanous FG. Cardiovascular effects of non-depolarizing neuromuscular blockers in patients with aortic valve disease. Can J Anaesth 1987;34:582-8.
26. Philbin DM, Machaj VR, Tomichek RC, et al. Hemodynamic effects of bolus injections of atracurium in patients with coronary artery disease. Br J Anaesth 1983;55(Suppl 1):131S-4S.
27. Basta SJ, Savarese JJ, Ali HH, et al. Histamine-releasing potencies of atracurium, dimethyl tubocurarine and tubocurarine. Br J Anaesth 1983;55(Suppl 1):105S-6S.
28. Cook DJ, Reeve BK, Guyatt GH, et al. Stress ulcer prophylaxis in critically ill patients: resolving discordant meta-analyses. JAMA 1996;275:308-14.
29. de Jong DM, Hoogerwerf N, Scheffaer GJ, et al. Atracurium induced vasodilatation is not mediated by histamine in the isolated femoral artery of the rabbit. Eur J Anaesthesiol 1996;13: 333-9.
30. Hennis PJ, Fahey MR, Canfell PC, et al. Pharmacology of laudanosine in dogs. Anesthesiology 1986;65:56-60.
31. Lindegaard K, Aaslid R, Nornes H. Cerebral arteriovenous malformations. In: Aaslid R, ed. Transcranial Doppler sonography. New-York: Springer, 1987:86-105.
32. Scott RP, Savarese JJ, Basta SJ, et al. Atracurium: clinical strategies for preventing histamine release and attenuating the hemodynamic response. Br J Anaesth 1985;57:550-3.